X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
index medicus (9) 9
male (7) 7
oncology (7) 7
middle aged (6) 6
prostate cancer (6) 6
aged (5) 5
survival analysis (5) 5
cancer (4) 4
docetaxel (4) 4
medical prognosis (4) 4
medicine, general & internal (4) 4
metastasis (4) 4
abridged index medicus (3) 3
antineoplastic agents - therapeutic use (3) 3
cancer therapies (3) 3
hematology, oncology and palliative medicine (3) 3
medical research (3) 3
patients (3) 3
prostatic neoplasms - drug therapy (3) 3
survival (3) 3
treatment outcome (3) 3
adult (2) 2
aged, 80 and over (2) 2
analysis (2) 2
androgen antagonists - administration & dosage (2) 2
androgen antagonists - adverse effects (2) 2
androgens (2) 2
anemia (2) 2
animals (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
article (2) 2
biochemistry & molecular biology (2) 2
care and treatment (2) 2
clinical trials (2) 2
dk/atira/pure/subjectarea/asjc/2700/2730 (2) 2
female (2) 2
gastrointestinal diseases (2) 2
inflammation (2) 2
inflammatory bowel disease (2) 2
metastases (2) 2
mice (2) 2
neoplasm metastasis (2) 2
open-label (2) 2
patient preference (2) 2
prostate (2) 2
prostate-specific antigen (2) 2
prostatic neoplasms - radiotherapy (2) 2
prostatic neoplasms - surgery (2) 2
prostatic neoplasms, castration-resistant - drug therapy (2) 2
radiation (2) 2
radiation therapy (2) 2
stem cells (2) 2
zoledronic acid (2) 2
abiraterone (1) 1
abiraterone acetate - administration & dosage (1) 1
abiraterone acetate - adverse effects (1) 1
abiraterone acetate/administration & dosage (1) 1
abiraterone acetate/administration & dosage; abiraterone acetate/adverse effects; adult; aged; aged, 80 and over; androgen antagonists/administration & dosage; androgen antagonists/adverse effects; antineoplastic combined chemotherapy protocols/adverse effects; antineoplastic combined chemotherapy protocols/therapeutic use; humans; male; middle aged; neoplasm metastasis/drug therapy; neoplasm recurrence, local/drug therapy; prednisolone/administration & dosage; prednisolone/adverse effects; prostate-specific antigen/blood; prostatic neoplasms/drug therapy; prostatic neoplasms/mortality; prostatic neoplasms/radiotherapy; prostatic neoplasms/surgery; steroid 17-alpha-hydroxylase/antagonists & inhibitors; survival analysis (1) 1
absorptivity (1) 1
abstracts (1) 1
adjuvant chemotherapy (1) 1
age (1) 1
age factors (1) 1
aged patients (1) 1
ambiguity (1) 1
androgen antagonists/administration & dosage (1) 1
androgen deprivation therapy (1) 1
androgen suppression therapy (1) 1
androgen-deprivation therapy (1) 1
androstenols - therapeutic use (1) 1
anemia - etiology (1) 1
angiogenesis (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal, humanized (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents, hormonal - administration & dosage (1) 1
antineoplastic agents, hormonal - adverse effects (1) 1
antineoplastic combined chemotherapy protocols/adverse effects (1) 1
aspirin (1) 1
autoantibodies - blood (1) 1
avoidance behavior (1) 1
axitinib (1) 1
bacteria (1) 1
bacterial-growth (1) 1
bakterien (1) 1
bakterienwachstum (1) 1
barrier-layers (1) 1
barriereschicht (1) 1
binding (1) 1
biochemical research methods (1) 1
bladder (1) 1
bone (1) 1
breakdown (1) 1
cabazitaxel (1) 1
cancer research (1) 1
candida (1) 1
carcinoma, renal cell - drug therapy (1) 1
carcinoma, renal cell - secondary (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10024, pp. 1163 - 1177
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
The Lancet, ISSN 0140-6736, 12/2018, Volume 392, Issue 10162, pp. 2353 - 2366
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2014, Volume 32, Issue 4_suppl, pp. 188 - 188
Journal Article
Journal Article
Patient Preference and Adherence, ISSN 1177-889X, 04/2014, Volume 8, pp. 503 - 511
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2018, Volume 29, Issue 5, pp. 1235 - 1248
Abstract Background Adding abiraterone acetate with prednisolone (AAP) or docetaxel with prednisolone (DocP) to standard-of-care (SOC) each improved survival... 
Head-to-head | Treatment | Randomised | Abiraterone | Prostate cancer | Docetaxel | treatment | prostate cancer | randomised | abiraterone | head-to-head | docetaxel | Original
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. e16054 - e16054
Journal Article
Clinical Breast Cancer, ISSN 1526-8209, 2008, Volume 8, Issue 3, pp. 285 - 286
Journal Article
by Ogawa, H and Koyanagi, R and Kawada-Watanabe, E and Yamaguchi, J and Takagi, A and Hagiwara, N and Deedwania, P. C and Demicco, D. A and Breazna, A and Wun, C. C and Pedersen, T and Colhoun, H. M and Neil, A and Hitman, G and Nakanishi, K and Fukuda, S and Shimada, K and Ehara, S and Inanami, H and Matsumoto, K and Taguchi, H and Muro, T and Yoshikawa, J and Yoshiyama, M and Dimitriadis, K and Tsioufis, C and Tatsis, I and Chlapoutakis, G and Lioni, L and Tzamou, V and Kasiakogias, A and Thomopoulos, C and Tousoulis, D and Stefanadis, C and Terentes-Printzios, D and Vlachopoulos, C and Aznaouridis, K and Ioakeimidis, N and Parapid, B and Vukcevic, V and Obrenovic-Kircanski, B and Simic, D. V and Milic, N. M and Stojanov, V and Beleslin, B and Nedeljkovic, I and Nedeljkovic-Arsenovic, O. M. S and Ostojic, M. C and Kotecha, D and Krum, H and New, G and Eccleston, D and Collins, P and Flather, M and Pepper, J and Tomiyama, H and Odaira, M and Yoshida, M and Shiina, K and Matsumoto, C and Yamashina, A and Pastormerlo, L. E and Maffei, S and Chubuchny, V and Mazzone, A. M and Susini, C and Passino, C and Chiappino, D and Emdin, M and Clerico, A and Katsi, V and Souretis, G and Vlasseros, I and Vrachatis, D and Kallikazaros, I and Androulakis, E and Chatzistamatiou, E and Papageorgiou, N and Miliou, A and Siasos, G and Moustakas, G and Ochoa, J. E and Balparda, J. K and Correa, M. M and Valencia, A. M and Alvarez, M and Mcewen, J. G and Bilo, G and Salvi, P and Aristizabal, D and Parati, G and De Vries, H and Engen-Verheul, M and Kemps, H. M. C and Kraaijenhagen, R and Peek, N and Vervueren, P. L and Bongard, V and Arveiler, D and Dallongeville, J and ... and on behalf of GEMI Group and on behalf of Korean Acute Myocardial Infarction Registry and on behalf of SWEETHEART-Study-Group and on behalf of QuIK Steering Committee and on behalf of On Behalf of the MADIT-CRT Investigators and on behalf of NAGOYA HEART Study Group and on behalf of Kan Wang, Xiaosheng Hu, Changqing Du, Shike Tu, Furong Zhang, and Xudong Xie and on behalf of The FRANCE2 scientific Committee and on behalf of Oslo Ischemia Study Group and on behalf of EUROVISION investigators and on behalf of German transcatheter aortic valve interventions registry and on behalf of Tokyo CCU network Committee and on behalf of Neha Singh and on behalf of the CASE-J Ex Study Group and on behalf of On behalf of Preserved-DATA-HELP (Diagnostic And TherApeutic methods, used in patients with systolic HEart failure, Living in Poland) investigators and on behalf of Associazione per lo Studio della Trombosi in Cardiologia and on behalf of BRAVO Investigators and on behalf of TIMI Study Group and on behalf of The Swedish Heart Failure Registry and on behalf of German Competence Network of Heart Failure and on behalf of Nordic ARVC Registry and on behalf of ACUITY and HORIZONS AMI and on behalf of Biomarkers in Cardiology and on behalf of Portuguese Registry of Acute Coronary Syndromes Investigators and on behalf of IMPROVE study group and on behalf of CLARICOR and on behalf of Department of Cardiology, Jinan Central Hospital Affiliated to Shandong University and on behalf of STAR-Study-Group and on behalf of DiaRegis-Study-Group and on behalf of MASS II Trial and on behalf of The Rotterdam Study and on behalf of the Korea Acute Myocardial Infarction Registry and on behalf of SACRA and PLUM registries investigators and on behalf of SMILE-4 and on behalf of AMIS Plus Investigators and on behalf of Gutenberg Heart Study and on behalf of VIPER-BP Study Investigators and on behalf of Hypersleep and on behalf of The CHART-2 Investigators and on behalf of HIJ-CREATE and on behalf of Joint "Croix Rouge Francaise" and "Federation Francaise de Cardiologie" Study Investigators and on behalf of ACTION and on behalf of EHS-PCI-Registry Study Group and on behalf of CCMR-3B Study Investigators and on behalf of The EURIKA investigators and on behalf of The GARFIELD Investigators and on behalf of a name and on behalf of RESET study investigators and on behalf of the SchlaHF-Investigators and on behalf of VIPER-BP Investigators and on behalf of ISSUE3 investigators and on behalf of FOCUS registry investigators and on behalf of NEO study and on behalf of cardiology unit, Ramathibodi hospital and on behalf of First Division of Cardiovascular Department, Chang Gung Memorial Hospital, Linkou and on behalf of Kyoto University/Canon joint research project and on behalf of The REACH registry investigators and on behalf of GCKD Study Investigators and on behalf of College National des Cardiologues des Hopitaux francais and on behalf of BBK registry Bad Krozingen and on behalf of PL-ACS Investigators and on behalf of the Three-City study Group and on behalf of Apixaban for Reduction In STroke and Other ThromboemboLic Events in Atrial Fibrillation and on behalf of ARISTOTLE Investigators and Committees and on behalf of Heart Cycle and on behalf of Electrophysiologist International Community "EPIC" Alliance and on behalf of MOMOTARO study and on behalf of BOREAS-TCM study and on behalf of BIOSOLVE-I Investigators and on behalf of On behalf of DATA-HELP study (Diagnostic And TherApeutic methods, used in patients with systolic HEart failure, Living in Poland) investigators and on behalf of FINN-AKVA study group
European Heart Journal, ISSN 0195-668X, 08/2012, Volume 33, Issue suppl 1, pp. 655 - 939
Journal Article
17.